Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway

22 Jan 2024

Abstract excerpt

Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder affecting a quarter of the global residents. Progression of NAFL into nonalcoholic steatohepatitis (NASH) may cause cirrhosis, liver cancer, and failure. Gut microbiota imbalance causes microbial components translocation into the circulation, triggering liver inflammation and NASH-related fibrosis. MicroRNAs (miRNAs) regulate gene expression via...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Circular RNAs in diseases
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38574101
DOI: 10.1002/ardp.202300631

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathwayPMID 38574101Read ↗

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectivesSemantic proximity Read ↗

From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patientsSemantic proximity Read ↗

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

miRNA Signature in NAFLD: A Turning Point for a Non-Invasive DiagnosisSemantic proximity Read ↗

Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive reviewSemantic proximity Read ↗

MicroRNAs and Nonalcoholic Steatohepatitis: A ReviewSemantic proximity Read ↗

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver diseaseSemantic proximity Read ↗

Disrupted Host-Microbiota Crosstalk Promotes Nonalcoholic Fatty Liver Disease Progression by Impaired MitophagySemantic proximity Read ↗

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)Semantic proximity Read ↗

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read ↗

MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.Semantic proximity Read ↗

Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.